Navigating the Immunotherapy Maze
Today, the global immunotherapy drugs market is valued at €139B ($163B) and is estimated to…
Today, the global immunotherapy drugs market is valued at €139B ($163B) and is estimated to…
Novel immunotherapies, like T cell therapy, may have shown recent successes but they also come…
Novartis’ Kymriah, one of the first CAR T-cell therapies to be approved to treat blood…
The Dutch startup Neogene Therapeutics has become the second T-cell therapy developer to raise a…
With the help of a huge €66M Series A round last week, the German startup…
The cell and gene therapy sector is booming. At the end of 2019, there were…
An international research team has found a new type of T-cell that could lead to…
The UK biotech Adaptimmune Therapeutics has inked a deal worth up to €806M with Japanese…
A CAR T-cell therapy amplified by RNA technology, developed by BioNTech, has shown preclinical potential…
With the year coming to a close, it’s time to review the most important biotech…
London-based Autolus has shown its next-generation CAR T-cell therapy does not induce some of the…
An off-the-shelf, gene edited CAR T-cell therapy, developed by the French biotech Cellectis, could be…